Efficacy and safety of paliperidone palmitate 3-monthly versus 1-monthly formulation in Asian patients with schizophrenia: Subgroup analysis of a randomized, double-blind, noninferiority study

被引：0
|
作者：
Savitz, A. [1 ]
Gopal, S. [1 ]
Xu, H. [1 ]
Zhuo, J. [2 ]
Yu, L. [2 ]
Nuamah, I. [1 ]
Wu, C. [2 ]
Hough, D. [1 ]
Mathews, M. [1 ]
Feng, Y. [2 ]
机构：
[1] Janssen Res & Dev, Titusville, NJ USA
[2] Janssen Res & Dev, Beijing, Peoples R China
来源：
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY | 2016年 / 19卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
PM419
引用
收藏
页码：201 / 201
页数：1
相关论文
共 50 条
  • [41] A Randomized, Double-Blind, Multicenter, Noninferiority Study Comparing Paliperidone Palmitate 6-Month Versus the 3-Month Long-Acting Injectable in Patients With Schizophrenia
    Najarian, Dean
    Sanga, Panna
    Wang, Steven
    Lim, Pilar
    Singh, Arun
    Robertson, Mary Jane
    Cohen, Kristin
    Schotte, Alain
    Milz, Ruth
    Venkatasubramanian, Raja
    T'Jollyn, Huybrecht
    Walling, David P.
    Galderisi, Silvana
    Gopal, Srihari
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2022, 25 (03): : 238 - 251
  • [42] A randomized, double-blind, placebo-controlled, dose-response efficacy and safety study of paliperidone palmitate in adults with schizophrenia
    Pandina, G.
    Lindenmayer, J. -P.
    Lull, J.
    Lim, P.
    Gopal, S.
    Herben, V.
    Kusumakar, V.
    Yuen, E.
    Palumbo, J.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2010, 13 : 232 - 232
  • [43] Assessment of hospitalizations in schizophrenia patients treated with paliperidone 1-monthly (PP1M), paliperidone 3-monthly (PP3M), aripiprazole oncemonthly (AOM) and other oral antipsychotics (OAP) in clinical practice.
    Gutierrez Rojas, L.
    Sanchez Alonso, S.
    Garcia Dorado, M.
    Lopez, P.
    EUROPEAN PSYCHIATRY, 2021, 64 : S539 - S539
  • [44] Efficacy of aripirpazole once-monthly in Asian patients with schizophrenia: Secondary efficacy outcomes in a multicenter, randomized, double-blind, non-inferiority study versus oral aripiprazole
    Ishigooka, J.
    Nakamura, J.
    Shimizu, N.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2014, 17 : 62 - 62
  • [45] Asian Subgroup Analysis of the REMISSIO Study: A Long-Term Efficacy and Safety Study of Paliperidone Palmitate 3-month Formulation in Patients with Stable Schizophrenia in a Naturalistic Clinical Setting
    Chung, Young-Chul
    Yang, Yen Kuang
    Sulaiman, Ahmad Hatim
    Bergmans, Paul
    Tan, Wilson
    CLINICAL PSYCHOPHARMACOLOGY AND NEUROSCIENCE, 2022, 20 (03) : 427 - 439
  • [46] Efficacy and safety of paliperidone palmitate in adult patients with acutely symptomatic schizophrenia: a randomized, double-blind, placebo-controlled, dose-response study
    Gopal, Srihari
    Hough, David W.
    Xu, Haiyan
    Lull, Julia M.
    Gassmann-Mayer, Cristiana
    Remmerie, Bart M.
    Eerdekens, Marielle H.
    Brown, David W.
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2010, 25 (05) : 247 - 256
  • [47] HEALTH RESOURCE USE AND COST ANALYSIS OF SCHIZOPHRENIA PATIENTS PARTICIPATING IN A RANDOMIZED, MULTICENTER, DOUBLE-BLIND, RELAPSE PREVENTION STUDY OF PALIPERIDONE PALMITATE 3-MONTH FORMULATION
    Benson, C.
    Chirila, C.
    Graham, J.
    Radder, C.
    Zheng, Q.
    Woodruff, K.
    VALUE IN HEALTH, 2015, 18 (03) : A119 - A119
  • [48] Efficacy and safety of once-monthly injection of paliperidone palmitate in hospitalized Asian patients with acute exacerbated schizophrenia: an open-label, prospective, noncomparative study
    Li, HuaFang
    Turkoz, Ibrahim
    Zhang, Fan
    NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2016, 12 : 15 - 24
  • [49] Efficacy and safety of aripiprazole once-monthly versus oral aripiprazole in Chinese patients with acute schizophrenia: a multicenter, randomized, double-blind, non-inferiority study
    Le Xiao
    Qian Zhao
    An-ning Li
    Jushui Sun
    Bin Wu
    Lina Wang
    Honggeng Zhang
    Ruiling Zhang
    Keqing Li
    Xiaojin Xu
    Tiebang Liu
    Wenshun Zhang
    Shiping Xie
    Xiufeng Xu
    Yunlong Tan
    Kerang Zhang
    Hongyan Zhang
    Nianhong Guan
    Mingji Xian
    Motomichi Uki
    Gang Wang
    Psychopharmacology, 2022, 239 : 243 - 251
  • [50] Efficacy and safety of aripiprazole once-monthly versus oral aripiprazole in Chinese patients with acute schizophrenia: a multicenter, randomized, double-blind, non-inferiority study
    Xiao, Le
    Zhao, Qian
    Li, An-ning
    Sun, Jushui
    Wu, Bin
    Wang, Lina
    Zhang, Honggeng
    Zhang, Ruiling
    Li, Keqing
    Xu, Xiaojin
    Liu, Tiebang
    Zhang, Wenshun
    Xie, Shiping
    Xu, Xiufeng
    Tan, Yunlong
    Zhang, Kerang
    Zhang, Hongyan
    Guan, Nianhong
    Xian, Mingji
    Uki, Motomichi
    Wang, Gang
    PSYCHOPHARMACOLOGY, 2022, 239 (01) : 243 - 251
12345